These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 20876469)

  • 21. Paternal mosaicism of an STXBP1 mutation in OS.
    Saitsu H; Hoshino H; Kato M; Nishiyama K; Okada I; Yoneda Y; Tsurusaki Y; Doi H; Miyake N; Kubota M; Hayasaka K; Matsumoto N
    Clin Genet; 2011 Nov; 80(5):484-8. PubMed ID: 21062273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation.
    Kato M; Yamagata T; Kubota M; Arai H; Yamashita S; Nakagawa T; Fujii T; Sugai K; Imai K; Uster T; Chitayat D; Weiss S; Kashii H; Kusano R; Matsumoto A; Nakamura K; Oyazato Y; Maeno M; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Saito K; Hayasaka K; Matsumoto N; Saitsu H
    Epilepsia; 2013 Jul; 54(7):1282-7. PubMed ID: 23621294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel STXBP1 mutations in 2 patients with early infantile epileptic encephalopathy.
    Sampaio M; Rocha R; Biskup S; Leão M
    J Child Neurol; 2015 Apr; 30(5):622-4. PubMed ID: 23533165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy.
    Stamberger H; Nikanorova M; Willemsen MH; Accorsi P; Angriman M; Baier H; Benkel-Herrenbrueck I; Benoit V; Budetta M; Caliebe A; Cantalupo G; Capovilla G; Casara G; Courage C; Deprez M; Destrée A; Dilena R; Erasmus CE; Fannemel M; Fjær R; Giordano L; Helbig KL; Heyne HO; Klepper J; Kluger GJ; Lederer D; Lodi M; Maier O; Merkenschlager A; Michelberger N; Minetti C; Muhle H; Phalin J; Ramsey K; Romeo A; Schallner J; Schanze I; Shinawi M; Sleegers K; Sterbova K; Syrbe S; Traverso M; Tzschach A; Uldall P; Van Coster R; Verhelst H; Viri M; Winter S; Wolff M; Zenker M; Zoccante L; De Jonghe P; Helbig I; Striano P; Lemke JR; Møller RS; Weckhuysen S
    Neurology; 2016 Mar; 86(10):954-62. PubMed ID: 26865513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome--result of Japanese cohort study.
    Otsuka M; Oguni H; Liang JS; Ikeda H; Imai K; Hirasawa K; Imai K; Tachikawa E; Shimojima K; Osawa M; Yamamoto T
    Epilepsia; 2010 Dec; 51(12):2449-52. PubMed ID: 21204804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ohtahara syndrome with emphasis on recent genetic discovery.
    Pavone P; Spalice A; Polizzi A; Parisi P; Ruggieri M
    Brain Dev; 2012 Jun; 34(6):459-68. PubMed ID: 21967765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intellectual disability without epilepsy associated with STXBP1 disruption.
    Hamdan FF; Gauthier J; Dobrzeniecka S; Lortie A; Mottron L; Vanasse M; D'Anjou G; Lacaille JC; Rouleau GA; Michaud JL
    Eur J Hum Genet; 2011 May; 19(5):607-9. PubMed ID: 21364700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features.
    Selmer KK; Lund C; Brandal K; Undlien DE; Brodtkorb E
    Epilepsy Behav; 2009 Nov; 16(3):555-7. PubMed ID: 19782004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype.
    Romaniello R; Saettini F; Panzeri E; Arrigoni F; Bassi MT; Borgatti R
    Neuroreport; 2015 Mar; 26(5):254-7. PubMed ID: 25714420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation.
    Dilena R; Striano P; Traverso M; Viri M; Cristofori G; Tadini L; Barbieri S; Romeo A; Zara F
    Brain Dev; 2016 Jan; 38(1):128-31. PubMed ID: 26212315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis.
    Marini C; Scheffer IE; Nabbout R; Mei D; Cox K; Dibbens LM; McMahon JM; Iona X; Carpintero RS; Elia M; Cilio MR; Specchio N; Giordano L; Striano P; Gennaro E; Cross JH; Kivity S; Neufeld MY; Afawi Z; Andermann E; Keene D; Dulac O; Zara F; Berkovic SF; Guerrini R; Mulley JC
    Epilepsia; 2009 Jul; 50(7):1670-8. PubMed ID: 19400878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and genetic characteristics of children with STXBP1 encephalopathy].
    Cao JJ; Ji XN; Mao YY; Zhang PP; Liu WT; Zhang HZ; Ding N; Chen Q
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):493-498. PubMed ID: 32521962
    [No Abstract]   [Full Text] [Related]  

  • 33. Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified.
    Zucca C; Redaelli F; Epifanio R; Zanotta N; Romeo A; Lodi M; Veggiotti P; Airoldi G; Panzeri C; Romaniello R; De Polo G; Bonanni P; Cardinali S; Baschirotto C; Martorell L; Borgatti R; Bresolin N; Bassi MT
    Arch Neurol; 2008 Apr; 65(4):489-94. PubMed ID: 18413471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A possible link between KCNQ2- and STXBP1-related encephalopathies: STXBP1 reduces the inhibitory impact of syntaxin-1A on M current.
    Devaux J; Dhifallah S; De Maria M; Stuart-Lopez G; Becq H; Milh M; Molinari F; Aniksztejn L
    Epilepsia; 2017 Dec; 58(12):2073-2084. PubMed ID: 29067685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ataxia, tremor, intellectual disability: a case of STXBP1 encephalopathy with a new mutation.
    Değerliyurt A; Kesen GG; Ceylaner S
    Turk J Pediatr; 2019; 61(5):757-759. PubMed ID: 32105008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STXBP1 encephalopathy is associated with awake bruxism.
    Rezazadeh A; Uddin M; Snead OC; Lira V; Silberberg A; Weiss S; Donner EJ; Zak M; Bradbury L; Scherer SW; Fasano A; Andrade DM
    Epilepsy Behav; 2019 Mar; 92():121-124. PubMed ID: 30654231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and genetic diagnosis of Dravet syndrome: report of 20 cases].
    Siegler Z; Neuwirth M; Hegyi M; Paraicz E; Pálmafy B; Tegzes A; Barsi P; Karcagi V; Claes L; De Jonghe P; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2008 Nov; 61(11-12):402-8. PubMed ID: 19070316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies.
    Abramov D; Guiberson NGL; Burré J
    J Neurochem; 2021 Apr; 157(2):165-178. PubMed ID: 32643187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The adult motor phenotype of Dravet syndrome is associated with mutation of the STXBP1 gene and responds well to cannabidiol treatment.
    Álvarez Bravo G; Yusta Izquierdo A
    Seizure; 2018 Aug; 60():68-70. PubMed ID: 29929108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.